A comprehensive view of American Academy of Allergy, Asthma and Immunology Annual Meeting. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Dupixent shows promising results in reducing airway inflammation and mucus build-up in adults with severe asthma, according to Sanofi; the findings were presented at the 2024 American Academy of Allergy, Asthma, and Immunology Annual Meeting
Published: February 24, 2024 by Sanofi SA
Intrommune Therapeutics reveals positive data supporting Oral Mucosal Immunotherapy as a potential treatment for food allergies; the findings indicate that specially formulated toothpaste can deliver allergenic proteins
Published: February 22, 2024 by GlobeNewswire
Sanofi's Dupixent and rilzabrutinib treatments show promise in improving lung function and providing relief for inflammatory diseases such as moderate-to-severe asthma and eosinophilic esophagitis; data presented at the AAAAI Annual Meeting
Published: February 09, 2024 by Sanofi SA

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count